PATENT CLAIM ANALYSIS

Application Number: 15910206
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "146100"]

Abstract:
A monoclonal antibody that binds to a phospholipase D4 (PLD4) protein, or a fragment containing an antigen-binding region thereof.

Claim (Index 46):
The method of  claim 44 , wherein the antibody or antigen-binding fragment thereof is humanized.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.04545
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14375266', '14113904', '14649297', '14360694', '14257480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7115723935450314
- 35 USC 102 Novelty (BERT): 0.6018066549068515
- Combined Prediction Score: 0.7005958196812134
- Mean Citation Score: 353.882578
- Max Citation Score: 573.5748
- Similarity Product: 422.84414131278993

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test